Furthermore, it is conceivable to suggest that restoration of p53 and inhibition of Plk1 will synergistically hinder relapse and metastasis of cancer, as p53 controls stem cell reprogramming and Plk1 inhibition eliminates tumor-initiating cells [28-31]. The gene discussed is TP53; the disease is cancer.